Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Prostate Adenocarcinoma × Radium-223 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Prostate Adenocarcinoma 1

Interventions

enzalutamide 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Biopsy 2 relugolix 1 luprolide acetate gel depot 1 gallium 68 PSMA-11 1 abiraterone 1 X-Rays 1 Radium-223 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Radiation 1 Prednisone 1 Lymph Node Excision 1 Glutamate Carboxypeptidase II 1 Abiraterone Acetate 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04704505 2026-02-06

BAT-RAD

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡